Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
Osame
M
M
Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Japan.
Nakagawa
M
M
Umehara
F
F
Ijichi
S
S
Moritoyo
T
T
Higuchi
I
I
Usuku
K
K
Arimura
K
K
Izumo
S
S
D001781:Blood Component Removal; D001812:Blood-Brain Barrier; D001921:Brain / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007564:Japan / Q000453:epidemiology; D008954:Models, Biological; D009474:Neurons / Q000473:pathology; D015493:Paraparesis, Tropical Spastic / Q000453:epidemiology* / Q000503:physiopathology* / Q000628:therapy; D010277:Parasympathomimetics / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011427:Propiophenones / Q000627:therapeutic use
D010277:Parasympathomimetics; D011427:Propiophenones; C030848:eperisone; D011239:Prednisolone; D006854:Hydrocortisone